Latest Insider Transactions at Albireo Pharma, Inc. (ALBO)
This section provides a real-time view of insider transactions for Albireo Pharma, Inc. (ALBO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALBIREO PHARMA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALBIREO PHARMA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
David Chiswell Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
56,278
-100.0%
|
-
|
|
Mar 02
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,739
-100.0%
|
-
|
|
Mar 02
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,242
-100.0%
|
-
|
|
Mar 02
2023
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
33,094
-100.0%
|
-
|
|
Mar 02
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,543
-100.0%
|
-
|
|
Mar 02
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,656
-50.01%
|
-
|
|
Mar 02
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
35,524
-100.0%
|
-
|
|
Mar 02
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,296
-100.0%
|
-
|
|
Jan 23
2023
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
1,057
-1.81%
|
$45,451
$43.8 P/Share
|
|
Jan 23
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
228
-1.59%
|
$9,804
$43.8 P/Share
|
|
Jan 23
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
102
-0.31%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
197
-0.36%
|
$8,471
$43.8 P/Share
|
|
Jan 23
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
102
-0.41%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
102
-0.24%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
120
-0.82%
|
$5,160
$43.8 P/Share
|
|
Jan 19
2023
|
Jason Duncan Chief Legal Officer and GC |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+44.3%
|
-
|
|
Jan 19
2023
|
Martha J. Carter Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+44.17%
|
-
|
|
Jan 19
2023
|
Jan Mattsson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+33.44%
|
-
|
|
Jan 19
2023
|
Ronald Harold Wilfred Cooper President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
195,000
+43.58%
|
-
|
|
Jan 19
2023
|
Paul Streck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+31.62%
|
-
|
|
Jan 19
2023
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+36.01%
|
-
|
|
Jan 19
2023
|
Simon N.R. Harford CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+38.55%
|
-
|
|
Jan 19
2023
|
Michelle Graham Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+36.16%
|
-
|
|
Jan 19
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,776
-5.14%
|
$76,368
$43.8 P/Share
|
|
Jan 19
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,774
-6.73%
|
$76,282
$43.9 P/Share
|
|
Jan 19
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,088
-5.35%
|
$132,784
$43.8 P/Share
|
|
Jan 19
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,774
-3.97%
|
$76,282
$43.9 P/Share
|
|
Jan 19
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
938
-6.13%
|
$40,334
$43.9 P/Share
|
|
Jan 19
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
938
-6.03%
|
$40,334
$43.9 P/Share
|
|
Dec 27
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
469
-1.03%
|
$8,911
$19.06 P/Share
|
|
Dec 19
2022
|
Paul Streck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,966
+50.0%
|
-
|
|
Dec 01
2022
|
Craig C. Hopkinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,495
+50.0%
|
-
|
|
Oct 24
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
919
-1.63%
|
$17,461
$19.58 P/Share
|
|
Oct 24
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
104
-0.66%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
104
-0.31%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
104
-0.39%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
202
-0.35%
|
$3,838
$19.58 P/Share
|
|
Oct 24
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
656
-1.42%
|
$12,464
$19.51 P/Share
|
|
Oct 24
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
104
-0.23%
|
$1,976
$19.58 P/Share
|
|
Oct 13
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
179,132
-4.23%
|
$3,940,904
$22.4 P/Share
|
|
Oct 12
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
97,219
-2.2%
|
$2,138,818
$22.75 P/Share
|
|
Oct 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
80
-0.24%
|
$1,840
$23.79 P/Share
|
|
Oct 11
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,065
-2.06%
|
$3,457,560
$24.06 P/Share
|
|
Sep 26
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
445
-0.96%
|
$8,455
$19.4 P/Share
|
|
Jul 25
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
313
-0.99%
|
$7,512
$24.03 P/Share
|
|
Jul 22
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
205
-0.35%
|
$4,920
$24.68 P/Share
|
|
Jul 22
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
106
-0.67%
|
$2,544
$24.68 P/Share
|
|
Jul 22
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
106
-0.4%
|
$2,544
$24.67 P/Share
|
|
Jul 22
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
106
-0.32%
|
$2,544
$24.67 P/Share
|
|
Jul 22
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
106
-0.23%
|
$2,544
$24.67 P/Share
|